229 related articles for article (PubMed ID: 7510833)
1. Deletion and duplication sequences induced in CHO cells by teniposide (VM-26), a topoisomerase II targeting drug, can be explained by the processing of DNA nicks produced by the drug-topoisomerase interaction.
Ripley LS
Mutat Res; 1994 Apr; 312(2):67-78. PubMed ID: 7510833
[TBL] [Abstract][Full Text] [Related]
2. DNA nick processing by exonuclease and polymerase activities of bacteriophage T4 DNA polymerase accounts for acridine-induced mutation specificities in T4.
Kaiser VL; Ripley LS
Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2234-8. PubMed ID: 7892253
[TBL] [Abstract][Full Text] [Related]
3. Small deletion and insertion mutations induced by the topoisomerase II inhibitor teniposide in CHO cells and comparison with sites of drug-stimulated DNA cleavage in vitro.
Han YH; Austin MJ; Pommier Y; Povirk LF
J Mol Biol; 1993 Jan; 229(1):52-66. PubMed ID: 8380617
[TBL] [Abstract][Full Text] [Related]
4. Enhanced amsacrine-induced mutagenesis in plateau-phase Chinese hamster ovary cells, with targeting of +1 frameshifts to free 3' ends of topoisomerase II cleavable complexes.
Patteson K; Wang P; Povirk LF
Cancer Res; 1999 Aug; 59(15):3682-8. PubMed ID: 10446982
[TBL] [Abstract][Full Text] [Related]
5. The specificity of topoisomerase-mediated DNA cleavage defines acridine-induced frameshift specificity within a hotspot in bacteriophage T4.
Masurekar M; Kreuzer KN; Ripley LS
Genetics; 1991 Mar; 127(3):453-62. PubMed ID: 1849858
[TBL] [Abstract][Full Text] [Related]
6. Effects of DNA topoisomerase inhibitors on nonhomologous and homologous recombination in mammalian cells.
Aratani Y; Andoh T; Koyama H
Mutat Res; 1996 Feb; 362(2):181-91. PubMed ID: 8596537
[TBL] [Abstract][Full Text] [Related]
7. A proflavin-induced frameshift hotspot in the thymidylate synthase gene of bacteriophage T4.
Brown MD; Ripley LS; Hall DH
Mutat Res; 1993 Apr; 286(2):189-97. PubMed ID: 7681530
[TBL] [Abstract][Full Text] [Related]
8. Hotspot sites for acridine-induced frameshift mutations in bacteriophage T4 correspond to sites of action of the T4 type II topoisomerase.
Ripley LS; Dubins JS; deBoer JG; DeMarini DM; Bogerd AM; Kreuzer KN
J Mol Biol; 1988 Apr; 200(4):665-80. PubMed ID: 2842508
[TBL] [Abstract][Full Text] [Related]
9. Drug-specific sites of topoisomerase II DNA cleavage in Drosophila chromatin: heterogeneous localization and reversibility.
Borgnetto ME; Zunino F; Tinelli S; Kas E; Capranico G
Cancer Res; 1996 Apr; 56(8):1855-62. PubMed ID: 8620504
[TBL] [Abstract][Full Text] [Related]
10. Single base-pair deletions induced by bleomycin at potential double-strand cleavage sites in the aprt gene of stationary phase Chinese hamster ovary D422 cells.
Povirk LF; Bennett RA; Wang P; Swerdlow PS; Austin MJ
J Mol Biol; 1994 Oct; 243(2):216-26. PubMed ID: 7523683
[TBL] [Abstract][Full Text] [Related]
11. A precise interchromosomal reciprocal exchange between hot spots for cleavable complex formation by topoisomerase II in amsacrine-treated Chinese hamster ovary cells.
Zhou RH; Wang P; Zou Y; Jackson-Cook CK; Povirk LF
Cancer Res; 1997 Nov; 57(21):4699-702. PubMed ID: 9354424
[TBL] [Abstract][Full Text] [Related]
12. The spectrum of acridine resistant mutants of bacteriophage T4 reveals cryptic effects of the tsL141 DNA polymerase allele on spontaneous mutagenesis.
Wang FJ; Ripley LS
Genetics; 1998 Apr; 148(4):1655-65. PubMed ID: 9560385
[TBL] [Abstract][Full Text] [Related]
13. Similar sequence specificity of mitoxantrone and VM-26 stimulation of in vitro DNA cleavage by mammalian DNA topoisomerase II.
Capranico G; De Isabella P; Tinelli S; Bigioni M; Zunino F
Biochemistry; 1993 Mar; 32(12):3038-46. PubMed ID: 8384486
[TBL] [Abstract][Full Text] [Related]
14. Expression of a mutant DNA topoisomerase II in CCRF-CEM human leukemic cells selected for resistance to teniposide.
Bugg BY; Danks MK; Beck WT; Suttle DP
Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7654-8. PubMed ID: 1652758
[TBL] [Abstract][Full Text] [Related]
15. Chinese hamster ovary cells resistant to the topoisomerase II catalytic inhibitor ICRF-159: a Tyr49Phe mutation confers high-level resistance to bisdioxopiperazines.
Sehested M; Wessel I; Jensen LH; Holm B; Oliveri RS; Kenwrick S; Creighton AM; Nitiss JL; Jensen PB
Cancer Res; 1998 Apr; 58(7):1460-8. PubMed ID: 9537249
[TBL] [Abstract][Full Text] [Related]
16. Analysis of eukaryotic topoisomerase II cleavage sites in the presence of the quinolone CP-115,953 reveals drug-dependent and -independent recognition elements.
Spitzner JR; Chung IK; Gootz TD; McGuirk PR; Muller MT
Mol Pharmacol; 1995 Aug; 48(2):238-49. PubMed ID: 7651357
[TBL] [Abstract][Full Text] [Related]
17. Mammalian topoisomerase II activity is modulated by the DNA minor groove binder distamycin in simian virus 40 DNA.
Fesen M; Pommier Y
J Biol Chem; 1989 Jul; 264(19):11354-9. PubMed ID: 2544590
[TBL] [Abstract][Full Text] [Related]
18. Integration of simian virus 40 into cellular DNA occurs at or near topoisomerase II cleavage hot spots induced by VM-26 (teniposide).
Bodley AL; Huang HC; Yu C; Liu LF
Mol Cell Biol; 1993 Oct; 13(10):6190-200. PubMed ID: 8413219
[TBL] [Abstract][Full Text] [Related]
19. Local base sequence preferences for DNA cleavage by mammalian topoisomerase II in the presence of amsacrine or teniposide.
Pommier Y; Capranico G; Orr A; Kohn KW
Nucleic Acids Res; 1991 Nov; 19(21):5973-80. PubMed ID: 1658748
[TBL] [Abstract][Full Text] [Related]
20. A unique type II topoisomerase mutant that is hypersensitive to a broad range of cleavage-inducing antitumor agents.
O'Reilly EK; Kreuzer KN
Biochemistry; 2002 Jun; 41(25):7989-97. PubMed ID: 12069589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
